Ítem
Acceso Abierto
Conserved binding regions provide the clue for peptide-based vaccine development: A chemical perspective
Título de la revista
Autores
Curtidor, Hernando
Reyes, César
Bermudez, Adriana
Vanegas, Magnolia
Varela, Yahson
Patarroyo, Manuel E
Archivos
Fecha
2017
Directores
ISSN de la revista
Título del volumen
Editor
MDPI AG
Buscar en:
Métricas alternativas
Resumen
Abstract
Synthetic peptides have become invaluable biomedical research and medicinal chemistry tools for studying functional roles, i.e., binding or proteolytic activity, naturally-occurring regions' immunogenicity in proteins and developing therapeutic agents and vaccines. Synthetic peptides can mimic protein sites; their structure and function can be easily modulated by specific amino acid replacement. They have major advantages, i.e., they are cheap, easily-produced and chemically stable, lack infectious and secondary adverse reactions and can induce immune responses via T- and B-cell epitopes. Our group has previously shown that using synthetic peptides and adopting a functional approach has led to identifying Plasmodium falciparum conserved regions binding to host cells. Conserved high activity binding peptides' (cHABPs) physicochemical, structural and immunological characteristics have been taken into account for properly modifying and converting them into highly immunogenic, protection-inducing peptides (mHABPs) in the experimental Aotus monkey model. This article describes stereo-electron and topochemical characteristics regarding major histocompatibility complex (MHC)-mHABP-T-cell receptor (TCR) complex formation. Some mHABPs in this complex inducing long-lasting, protective immunity have been named immune protection-inducing protein structures (IMPIPS), forming the subunit components in chemically synthesized vaccines. This manuscript summarizes this particular field and adds our recent findings concerning intramolecular interactions (H-bonds or-interactions) enabling proper IMPIPS structure as well as the peripheral flanking residues (PFR) to stabilize the MHCII-IMPIPS-TCR interaction, aimed at inducing long-lasting, protective immunological memory. © 2017 by the authors. Licensee MDPI, Basel, Switzerland.1.
Palabras clave
Keywords
Lymphocyte antigen receptor , Malaria vaccine , Peptide , Protein binding , Amino acid sequence , Animal , Binding site , Chemistry , Haplorhini , Human , Immunology , Major histocompatibility complex , Metabolism , Molecular model , Plasmodium falciparum , Protein conformation , Amino acid sequence , Animals , Binding sites , Haplorhini , Humans , Major histocompatibility complex , Malaria vaccines , Models , Peptides , Plasmodium falciparum , Protein binding , Protein conformation , Receptors , Immunogenicity , Malaria vaccine , Structure , Synthetic peptides , Therapeutics
